China Pioneer Pharma Holdings Limited
HKEX:1345.HK
2.01 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 114.427 | 214.008 | 224.851 | 115.009 | 270.284 | 150.854 | 226.154 | 309.64 | 317.113 | 260.834 | 702.073 | 59.559 |
Short Term Investments
| 10 | 75 | 177.23 | 139.6 | 198.546 | 47 | 50 | 0 | 0 | 10 | 60 | 0 |
Cash and Short Term Investments
| 124.427 | 289.008 | 402.081 | 254.609 | 468.83 | 197.854 | 276.154 | 309.64 | 317.113 | 260.834 | 781.902 | 59.559 |
Net Receivables
| 448.418 | 413.154 | 251.84 | 288.04 | 269.609 | 310.269 | 526.566 | 450.658 | 413.619 | 545.019 | 316.648 | 0 |
Inventory
| 417.934 | 321.132 | 294.947 | 448.73 | 393.574 | 419.744 | 623.388 | 520.244 | 663.249 | 619.969 | 419.844 | 295.862 |
Other Current Assets
| 564.568 | 494.789 | 316.114 | 423.799 | 371.896 | 467.99 | 630.297 | 579.191 | 557.128 | 1,120.446 | 640.287 | 511.553 |
Total Current Assets
| 1,106.929 | 1,134.929 | 1,013.142 | 1,127.138 | 1,234.085 | 1,083.231 | 1,529.839 | 1,409.075 | 1,537.49 | 2,011.249 | 1,842.033 | 866.974 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 247.44 | 221.565 | 91.101 | 80.845 | 55.206 | 46.144 | 52.336 | 49.853 | 76.497 | 103.737 | 17.219 | 11.312 |
Goodwill
| 6.213 | 6.213 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42.265 | 0 | 0 |
Intangible Assets
| 30.191 | 37.048 | 45.923 | 47.031 | 11.98 | 14.106 | 15.187 | 15.883 | 61.207 | 158.427 | 15.221 | 18.23 |
Goodwill and Intangible Assets
| 36.404 | 43.261 | 45.923 | 47.031 | 11.98 | 14.106 | 15.187 | 15.883 | 61.207 | 200.692 | 15.221 | 18.23 |
Long Term Investments
| 117.138 | 156.157 | 82.165 | 80.657 | 139.206 | 52.799 | 92.053 | 109.223 | 67.07 | 65.152 | 76.952 | 0 |
Tax Assets
| 0 | 8.598 | 11.958 | 19.524 | 7.788 | 8.578 | 5.373 | 5.947 | 2.132 | 2.286 | 2.142 | 6.331 |
Other Non-Current Assets
| 22.994 | -8.598 | -11.958 | -19.524 | -7.788 | -8.578 | -5.373 | -5.947 | -2.132 | -2.286 | -2.142 | 25.706 |
Total Non-Current Assets
| 423.976 | 420.983 | 219.189 | 208.533 | 206.392 | 113.049 | 159.576 | 174.959 | 204.774 | 369.581 | 109.392 | 61.579 |
Total Assets
| 1,530.905 | 1,571.667 | 1,328.477 | 1,428.442 | 1,550.586 | 1,437.844 | 1,834.046 | 1,748.472 | 1,822.024 | 2,554.851 | 1,996.915 | 928.553 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 284.946 | 323.522 | 259.964 | 360.718 | 263.532 | 200.097 | 626.439 | 481.925 | 471.69 | 473.7 | 360.742 | 244.356 |
Short Term Debt
| 61.272 | 29.586 | 13.979 | 15.104 | 48.961 | 101.137 | 34.336 | 79.437 | 287.878 | 611.106 | 429.545 | 416.22 |
Tax Payables
| 17.777 | 39.784 | 24.901 | 31.807 | 31.28 | 14.489 | 16.446 | 28.598 | 14.778 | 14.741 | 7.281 | 5.989 |
Deferred Revenue
| 0 | -29.586 | -13.979 | -15.104 | -48.961 | -101.137 | -34.336 | -79.437 | -287.878 | -611.106 | -429.545 | 54.692 |
Other Current Liabilities
| 78.695 | 79.954 | 49.351 | 76.834 | 55.357 | 14.25 | 1.886 | 4.713 | 1.87 | 123.006 | 7.968 | 49.163 |
Total Current Liabilities
| 442.69 | 472.846 | 348.195 | 484.463 | 399.13 | 329.973 | 679.107 | 594.673 | 776.216 | 1,222.553 | 805.536 | 715.728 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 12.748 | 8.007 | 0.071 | 0 | 0.069 | 0 | 4.794 | 34.534 | 35.404 | 17.266 | 0 | 0 |
Deferred Revenue Non-Current
| 41.42 | 43.6 | 43.6 | 19.411 | -7.4 | 0 | 0 | 1.464 | 0.557 | 0 | -7.04 | 0 |
Deferred Tax Liabilities Non-Current
| 16.28 | 24.725 | 25.625 | 12.853 | 7.4 | 0 | 0 | 7.25 | 13.406 | 43.274 | 7.5 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 1.979 | 9.08 | 1.464 | 0.557 | 45.783 | 0.46 | 0 |
Total Non-Current Liabilities
| 70.448 | 76.332 | 69.296 | 32.264 | 7.469 | 1.979 | 13.874 | 43.248 | 49.367 | 106.323 | 0.46 | 660.576 |
Total Liabilities
| 513.138 | 549.178 | 417.491 | 516.727 | 406.599 | 331.952 | 692.981 | 637.921 | 825.583 | 1,328.876 | 839.63 | 715.728 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 84.067 | 59.039 | 214.167 | 150.054 | 101.836 | 69.289 | 75.682 | 94.428 | 93.079 | 57.084 | 0 |
Common Stock
| 77.399 | 77.399 | 77.566 | 77.566 | 77.566 | 79.071 | 81.391 | 82.096 | 82.096 | 82.096 | 82.096 | 0 |
Retained Earnings
| 634.88 | 594.845 | 444.205 | 590.461 | 538.013 | 433.386 | 361.481 | 297.85 | 202.905 | 181.35 | 175.623 | 88.478 |
Accumulated Other Comprehensive Income/Loss
| 0 | -84.067 | -59.039 | -214.167 | -150.054 | -101.836 | -69.289 | -75.682 | -94.428 | -93.079 | -57.084 | -7.135 |
Other Total Stockholders Equity
| 294.164 | 442.163 | 467.334 | 241.407 | 694.028 | 706.598 | 779.183 | 819.045 | 819.906 | 969.382 | 965.993 | 130.714 |
Total Shareholders Equity
| 1,006.443 | 1,007.804 | 907.97 | 909.434 | 1,141.548 | 1,104.576 | 1,140.123 | 1,110.859 | 998.09 | 1,127.36 | 1,157.628 | 212.057 |
Total Equity
| 1,017.767 | 1,022.489 | 910.986 | 911.715 | 1,143.987 | 1,105.892 | 1,141.065 | 1,110.551 | 996.441 | 1,225.975 | 1,157.285 | 212.825 |
Total Liabilities & Shareholders Equity
| 1,530.905 | 1,571.667 | 1,328.477 | 1,428.442 | 1,550.586 | 1,437.844 | 1,834.046 | 1,748.472 | 1,822.024 | 2,554.851 | 1,996.915 | 928.553 |